Synnovation Therapeutics logo
Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com
synnovationtx.com • 11-50 employees • Startup
11-50 employees • Startup
As featured in
businesswire
BioSpace
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
1
Nextech Invest
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 8, 2025 Board appointment Synnovation Therapeutics Announces the Appointment of Rafael G. Amado, M.D., to Its Board of Directors · BioSpace
Backed byfrom the funds' portfolios and accelerator catalogs
Nextech Invest fund
Investors in similar startupsfunds that back the companies most like this one
OrbiMed
backs Alumis, Alterome
Foresite Capital
backs Alumis
Canaan
backs Alterome
Alta Partners
backs Lassen
LAV
backs Elpiscience
Longitude Capital
backs Lassen
Similar startupsby what they do, their industry and backers
AlteromeVenture round $63.8M · 4 yr ago • Founded 2021 • 51-200 employees • 1 role
Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and…
Cleara BiotechSeed $2.5M · 4 yr ago • 11-50 employees
Cleara Biotech is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases.
SymPhysis MedicalVenture round $2.4M · 2 yr ago
SymPhysis Medical specializes in medical technology designed to improve the lives of patients with chronic conditions.
LassenVenture round $85M · 2 yr ago
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
ProTgenVenture round $8.2M · 22 mo ago • Founded 2023
ProTgen develops first-in-class targeted Notch activators that generate progenitor T cells to restore thymic function and immune competence.
ORIA Bioscience | Isolated Organelles for Drug DiscoveryFounded 2022
FROM CELLS TO ORGANELLES• ORGANELLES•. First-in-Class Isolated Organelles for Drug Discovery.

Overview

Synnovation is dedicated to the discovery and development of Best-In-Class targeted medicines. We are dedicated to the discovery and development of best-in-class therapeutics that can improve the lives of patients.

News